Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1033-1043

  Espinosa, Ana María ^a   Sierra, Adriana Yanett ^a   Barrero, Carlos Alberto ^a   Cepeda, Libia Alexandra ^a   Cantor, Elvia María ^a   Lombo, Tania Bibiana ^a   Guzmán, Fanny ^a   Avila, Sandra Julieta ^a   Patarroyo, Manuel Alfonso ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

Binding; MSP 1; Plasmodium vivax; Polymorphism

Indexed keywords

MALARIA VACCINE; PROTEIN MSP 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; AOTUS; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RABBIT; RETICULOCYTE; SEROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENIC VARIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; GENE EXPRESSION REGULATION; HUMANS; MALARIA VACCINES; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; RECOMBINANT FUSION PROTEINS; RETICULOCYTES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 0037424126     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00660-6     Document Type: Article

References (47)

1. The World Health Report. Making a difference. Geneva: World Health Organization (WHO); 1999.
2. Galinski M.R., Barnwell J.W. Plasmodium vivax: merozoites, invasion of reticulocytes, and considerations for malaria vaccine development. Parasitol. Today. 12:1996;20-29.
3. Levitus G., del Portillo H.A. Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax. Mem. Inst. Oswaldo Cruz. 89:1994;81-84.
4. Fang X.D., Kaslow D.C., Adams J.H., Miller L.H. Cloning of the Plasmodium vivax Duffy receptor. Mol. Biochem. Parasitol. 44:1991;125-132.
5. Adams J.H., Sim B.K., Dolan S.A., Fang X., Kaslow D.C., Miller L.H. A family of erythrocyte binding proteins of malarial parasites. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7085-7089.
6. Cheng Q., Saul A. Sequence analysis of apical membrane antigen I (AMA-I) of Plasmodium vivax. Mol. Biochem. Parasitol. 65:1994;183-187.
7. Galinski M.R., Corredor Medina C., Ingravallo P., Barnwell J.W. A reticulocyte-binding proteins complex of Plasmodium vivax merozoites. Cell. 69:1992;1213-1226.
8. Holder A.A., Lockyer M.J., Odink K.G.et al. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature. 317:1985;270-273.
9. Smythe J.A., Coppel R.L., Brown G.V., Ramasamy R., Kemp D.J., Anders R.F. Identification of two integral membrane proteins of Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5195-5199.
10. Marshall V.M., Silva A., Foley M.et al. A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain. Infect. Immun. 6:1997;4460-4467.
11. Trucco C., Fernandez-Reyes D., Howell S.et al. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol. Biochem. Parasitol. 112:2001;91-101.
12. Pachebat J.A., Ling I.T., Grainger M. The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol. Biochem. Parasitol. 117:2001;83-89.
13. Black C.G., Wu T., Wang L., Hibbs A.R., Coppel R.L. Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 114(2):2001;217-226.
14. Stahl H.D., Bianco A.E., Crewther P.E. Sorting large numbers of clones expressing Plasmodium falciparum antigens in Escherichia coli by differential antibody screening. Mol. Biol. Med. 3:1986;351-368.
15. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4030-4034.
16. Barnwell J.W., Galinski M.R., DeSimone S.G., Perler F., Ingravallo P. Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites. Exp. Parasitol. 91:1999;238-249.
17. Galinski M.R., Corredor-Medina C., Povoa M., Crosby J., Ingravallo P., Barnwell J.W. Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain. Mol. Biochem. Parasitol. 101:1999;131-147.
18. Black C.G., Barnwell J.W., Huber C.S., Galinski M.R., Coppel R.L. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite. Mol. Biochem. Parasitol. 120(2):2002;215-224.
19. Vargas-Serrato E., Barnwell J.W., Ingravallo P., Perler F.B., Galinski M.R. Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologus to p101/ABRA of P. falciparum. Mol. Biochem. Parasitol. 120(1):2002;41-52.
20. Blackman M.J., Whittle H., Holder A.A. Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 49:1991;35-44.
21. Haldar K., Ferguson M.A., Cross G.A. Acylation of Plasmodium falciparum merozoite surface antigen via sn-1,2-diacylglicerol. J. Biol. Chem. 260(8):1985;4969-4974.
22. Matsumoto S., Yukitake H., Kanbara H., Yamada T. Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP-1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J. Exp. Med. 188:1998;845-854.
23. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., Holder A.A. A single fragment of malaria merozoite surface protein remains on the parasite during red cell invasion and is target of invasion-inhibiting antibodies. J. Exp. Med. 172:1990;379-382.
24. Lakshman KLR, Haundunnetii SM, Holm I, Longacre S, Mendis K. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria, Infect Immun. 1998;1500-6.
25. Putaporntip C., Jongwutiwes S., Tanabe K., Thaithong S. Interallelic recombination in the merozoite surface protein 1 (MSP-1) gene of Plasmodium vivax from Thai isolates. Mol. Biochem. Parasitol. 84(1):1997;49-56.
26. Gibson H.L., Tucker J.E., Kaslow D.C.et al. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 50:1992;325-333.
27. Rodriguez L.E., Urquiza M., Ocampo M.et al. Plasmodium vivax MSP-1 peptides have high specific binding activity to human retyculocytes. Vaccine. 20(9):2002;1331-1339.
28. Gutierrez A., Vicini J., Patarroyo M.E., Murillo L.A., Patarroyo M.A. Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp. Parasitol. 95:2000;215-219.
29. Sambrook K, Fritsch EF, Maniatis T. Molecular cloning a laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76(9):1979;4350-4354.
32. Janknecht R., de Martynoff G., Lou J., Hipskind R.A., Nordheim A., Stunnenberg H.G. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8972-8976.
33. Kuusinen A., Arvola M., Oker-Blom C., Keinanen K. Purification of recombinant GluR-D glutamate receptor produced in Sf21 insect cells. Eur. J. Biochem. 233(3):1995;720-726.
34. Mallon F.M., Graichen M.E., Conway B.R., Landi M.S., Hughes H.C. Comparison of antibody response by use of synthetic adjuvant system and Freund complete adjuvant in rabbits. Am. J. Vet. Res. 52:1991;1503-1506.
35. Sarin V.K., Kent S.B., Tam J.P., Merrifield R.B. Quantitative monitoring of solid phase peptide synthesis by ninhydrin reaction. Anal. Biochem. 117:1981;147-157.
36. Tam J.P., Heath W.F., Merrifield R.B. SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J. Am. Chem. Soc. 105:1983;6442-6455.
37. Ternynck TH, Avrameas S. Immunoenzymatic techniques. Paris, Pasteur Institute: Elsevier Science Publishers; 1990.
38. Egan A., Waterfall M., Pinder M., Holder A., Riley E. Characterisation of human T and B-Cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-Cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun. 65:1997;3024-3031.
39. Soares I.S., Levitus G., Souza J.M., del Portillo H.A., Rodríguez M.M. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect. Immun. 65:1997;1606-1614.
40. Soares I.S., Barnwell J.W., Ferreira M.U., Gomes M., Laurino J.P., Casthilo B.A.et al. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol. Med. 5:1999;459-470.
41. Pasay M.C., Cheng Q., Rzepczyk C., Saul A. Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. Mol. Biochem. Parasitol. 70:1995;217-219.
42. Putaporntip C., Jongwutiwes S., Seethmchai S., Kanbara H., Tanabe K. Intragenic recombination in the 3′ portion of the merozoite surface protein 1 gene of Plasmodium vivax. Mol. Biochem. Parasitol. 109(2):2000;111-119.
43. Soares I.S., Da Cunha M.G., Silva M.N., Souza J.M., del Portillo H.A., Rodríguez M.M. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. Am. J. Trop. Med. Hyg. 60(3):1999;357-363.
44. Dutta S., Ware L.A., Barbosa A., Ockenhouse C.F., Lanar D.E. Purification, characterization and immnugenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen merozoite surface protein 1 expressed in Escherichia coli. Infect. Immun. 69:2001;5464-54670.
45. Mons B., Collins W.E., Skinner J.C., Star W., Croon J., Kaay H. Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai. Exp. Parasitol. 66(2):1988;83-88.
46. Barnwell J.W., Galinski M.R. The adhesion of malaria merozoite proteins to erythrocytes: a reflection of function? Res. Immunol. 142(8):1991;666-672.
47. Camus D., Hadley T.J. A Plasmodium falciparum antigen that bind to host erythrocytes and merozoites. Science. 230:1985;553-555.